Attenuated Modified Vaccinia Virus Ankara Can Be Used as an Immunizing Agent under Conditions of Preexisting Immunity to the Vector

A problem associated with the use of vaccinia virus recombinants as vaccines is the existence of a large human population with preexisting immunity to the vector. Here we showed that after a booster with attenuated recombinant modified vaccinia virus Ankara (rMVA), higher humoral and cellular immune...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Ramírez, Juan C., Gherardi, M. Magdalena, Rodríguez, Dolores, Esteban, Mariano
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2000
Soggetti:	Vaccines and Antiviral Agents
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC112288/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10906221/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.74.16.7651-7655.2000
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!